InMed Pharmaceuticals Inc. Common Shares

INM CA4576376012

💰
Capitalization
Small-cap

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

🔗
Website
https://www.inmedpharma.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
3
🙍
Insiders
3
Person Price Shares Total Published Completed
Mancini Alexandra Diane Janet
O 		0.18
USD 		240
Sold 		42
USD 		31/07/2024 31/07/2024
Hull Andrew
O 		0.39
USD 		37,500
Bought 		14,625
USD 		21/02/2024 21/02/2024
Adams Eric A
CEO 		0.36
USD 		41,600
Bought 		14,922
USD 		20/02/2024 20/02/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include InMed Pharmaceuticals Inc. Common Shares to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Adams Eric A 1 14,921.92 14,921.92 20/02/2024 20/02/2024
Hull Andrew 1 14,625.00 14,625.00 21/02/2024 21/02/2024
Mancini Alexandra Diane Janet 1 42.31 42.31 31/07/2024 31/07/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.